Programmdetails

Nitroxolin is a novel inhibitor of NLRP3-dependent pyroptosis

Antiplatelet and anticoagulant compound (APAC) restricts thromboinflammation to ameliorates myocardial ischemia reperfusion injury

Thrombin receptors as candidate therapeutic targets to prevent post-operative atrial fibrillation

Double-stranded RNA sensing links antiviral innate immunity with pulmonary endothelial barrier integrity

Expression of human ACE2 in cardiomyocytes promotes COVID-19 and transcriptional cardiac remodeling and viral replication in lungs of K18-hACE2 transgenic mice

ARDS disrupts cardiac macrophage subsets

Atherosclerosis licenses for an exceeding immune response in COVID-19 disease

Optimized assessement of infectious endocarditis with a novel wire-injury based murine model